Press Releases
Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012
2012 Archives
Nov 18, 2012 Renowned molecular geneticist strengthens Trovagene's scientific expertise
|
Nov 14, 2012 COMPANY CONTINUES TO DEVELOP PROGRAMS IN CANCER AND INFECTIOUS DISEASE DETECTION IN URINE
|
Aug 28, 2012 Issuance of First US NPM1 Patent Triggers Milestone Payment
|
Aug 14, 2012 COMPANY CONTINUES TO EXPAND PROGRAMS IN CANCER AND INFECTIOUS DISEASE DETECTION IN URINE
|
Jul 2, 2012 Study will compare detection of KRAS mutations in urine to their detection in biopsy samples
|
Jun 24, 2012
|
Apr 30, 2012 Internationally recognized cancer researcher and physician strengthens Trovagene's scientific expertise in cancer genetics
|
Apr 30, 2012 Trovagene Announces Validation Program for Trans-Renal K-RAS Mutation Detection in Pancreatic Cancer Company plans to establish comprehensive panel of assays to detect oncogene mutations in the urine of cancer patients
|
Apr 22, 2012 - Pharmaceutical and diagnostic sales and marketing executive will provide leadership to accelerate commercial programs -
|
1-25 26-30 |